Trigeminal Nerve Blocks for Medically Intractable Painful Trigeminal Neuropathy

Area of Science:

• Neurology
• Pain Management
• Anesthesiology

Background:

• Painful trigeminal neuropathy (PTN) is a severe condition causing persistent facial pain after nerve injury.
• It often resists medication and significantly impacts quality of life.
• Trigeminal nerve blocks (TNB) are explored as a treatment option.

Purpose of the Study:

• To evaluate the efficacy of trigeminal nerve blocks (TNB) for patients diagnosed with painful trigeminal neuropathy (PTN).
• To identify factors influencing the success and duration of pain relief from TNB.
• To assess the role of local anesthetics and steroid co-administration in TNB outcomes.

Main Methods:

• Retrospective chart review of 90 PTN patients who underwent TNB.
• Analysis of TNB procedures involving various local anesthetic combinations (lidocaine, ropivacaine, bupivacaine).
• Investigation of triamcinolone co-administration and its contraindications.

Main Results:

• 81.1% of patients experienced at least 50% pain reduction.
• Pain relief duration varied, with 50% reporting relief for ≥6 weeks.
• Effective regimens included combinations of local anesthetics with triamcinolone.

Conclusions:

• Trigeminal nerve blocks (TNB) with local anesthetics and steroids demonstrate efficacy in managing painful trigeminal neuropathy (PTN).
• Factors like depression, maxillary nerve involvement, and facial numbness may indicate poorer prognostic outcomes.
• TNB offers a viable therapeutic strategy for refractory PTN.